P&K Skin Research Center Co., Ltd. (347740.KQ)
KOSDAQ · KRW · Healthcare · Diagnostics & Research
₩1,793 (+1.36%) as of
Key statistics
- Market cap
- 51.79B
- Dividend yield
- 2.83%
- 52-week range
- 1,292.00 – 2,800.00
- Beta
- 0.83
- Revenue (TTM)
- 23.67B
- Profit margin
- 15.77%
- Volume
- 61.61k
About P&K Skin Research Center Co., Ltd.
P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 2010 and is headquartered in Seoul, South Korea. P&K Skin Research Center Co., Ltd. is a subsidiary of Daebongls.Co.,Ltd.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.